Neuroone Medical Technologies Corp expected to post a loss of 20  cents a share - Earnings Preview

Neuroone Medical Technologies

10/05/2022 13:46

* Neuroone Medical Technologies Corp  NMTC.OQ   NMTC.O  is
expected to report results on May 12.
    * ​Refinitiv's mean analyst estimate for Neuroone Medical
Technologies Corp is for a loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.63​, above​ its last closing price
of $0.60. ​​​

This summary was machine generated May 10 at 12:46 GMT.  All
figures in US dollars  unless otherwise stated